Home » Topics » Regulatory » Patents

Patents
RSS

New anti-HIV agents discovered by Hoechst

Nov. 19, 1996

NO donors reported for cancer chemotherapy

Nov. 19, 1996

Astra claims orally active peptide immunomodulators

Nov. 19, 1996

ET antagonists revealed by SmithKline Beecham

Nov. 19, 1996

EGFR tyrosine kinase inhibitors described by Pfizer

Nov. 19, 1996

RPR claims taxoid antineoplastic compounds

Nov. 19, 1996

Growth stimulant reported by American Cyanamid

Nov. 19, 1996

Hirudin-based thrombin inhibitors reported by Canadian investigators

Nov. 19, 1996

Glaxo Wellcome claims 5alpha-reductase inhibitors for BPH

Nov. 19, 1996

Novo Nordisk claims immunosuppressive serine palmitoyl transferase inhibitors

Nov. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...